Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Challenges and priorities for the MHRA - consultation (MLX 339)

Document details:

Type: Publication
Series No: 339
Audience: All
Published: 10 August 2007
Format: Electronic and paper
Size: A4
Pages: 16
Price: Free
ISBN/ISSN:
Author: MHRA
Copyright: Crown
   

The attached consultation sought views from our stakeholders on how we should respond to the key challenges and priorities for the coming years. Also attached is the publication “Medicines and Medical Devices Regulation – What you Need to Know” which includes a full explanation of what we do and how we do it.  When launching the consultation, Kent Woods, Chief Executive of the MHRA, said “As the Agency develops its strategy for its second five years, we need to gather the ideas and perceptions of the widest possible range of stakeholders.  The closing date for comments was 2 November 2007.

Summary of responses - 29 April 2008
A summary report on the issues raised by consultees in response to this consultation is available to download below.

The following table indicates how organisations responded to the consultation.

Ref
Organisation
1
2
3
4
5
6
8
9
10
SimuGen (58Kb)
11
12
13
14
15
16
17
18
19
20
21
22
GeneWatch UK (122Kb)
23
24
25
26
27
29
30
31
32
33
34
LGC Limited (160Kb)
35
Royal College of  Physicians Patient Forum Member (17Kb)
36
37
38
39
40
41
42
43
44
45
46
47
48
49
CMAS (9Kb)
50
51
52
53
54
55
56
57
58
59
60
61
Pfizer (45Kb)
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
Thyroid UK (11Kb)
78
79
80
82
ABRHP Member (106Kb)
83
*84
Rethink (35Kb)
85
86
87
88
UniChem Ltd (32Kb)
89
90
91
92



Page last modified: 29 October 2008